ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 242 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q3 2015. The put-call ratio across all filers is 0.09 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $448,494 | +1.5% | 34,132 | -2.7% | 0.00% | – |
Q2 2023 | $441,895 | -6.4% | 35,071 | -3.0% | 0.00% | – |
Q1 2023 | $471,966 | -27.6% | 36,166 | -2.1% | 0.00% | -100.0% |
Q4 2022 | $651,816 | +76.6% | 36,951 | +52.4% | 0.00% | – |
Q3 2022 | $369,000 | +27.2% | 24,253 | +24.0% | 0.00% | – |
Q2 2022 | $290,000 | -44.0% | 19,559 | -15.0% | 0.00% | – |
Q1 2022 | $518,000 | +11.2% | 23,006 | -9.0% | 0.00% | – |
Q4 2021 | $466,000 | +43.4% | 25,284 | +3.9% | 0.00% | – |
Q3 2021 | $325,000 | -21.3% | 24,334 | +9.0% | 0.00% | – |
Q2 2021 | $413,000 | +65.9% | 22,334 | +34.9% | 0.00% | – |
Q1 2021 | $249,000 | -7.1% | 16,556 | -10.6% | 0.00% | – |
Q4 2020 | $268,000 | -6.0% | 18,526 | -47.1% | 0.00% | – |
Q3 2020 | $285,000 | +3.3% | 35,011 | -14.0% | 0.00% | – |
Q2 2020 | $276,000 | -8.3% | 40,696 | -4.8% | 0.00% | – |
Q1 2020 | $301,000 | -34.4% | 42,761 | -8.6% | 0.00% | -100.0% |
Q4 2019 | $459,000 | -24.1% | 46,786 | -15.1% | 0.00% | 0.0% |
Q3 2019 | $605,000 | -6.5% | 55,131 | -1.0% | 0.00% | 0.0% |
Q2 2019 | $647,000 | +36.8% | 55,669 | +12.3% | 0.00% | 0.0% |
Q1 2019 | $473,000 | -68.7% | 49,586 | -68.4% | 0.00% | -66.7% |
Q4 2018 | $1,511,000 | -39.6% | 156,750 | -10.7% | 0.00% | -25.0% |
Q3 2018 | $2,501,000 | +104.0% | 175,501 | +71.8% | 0.00% | +100.0% |
Q2 2018 | $1,226,000 | +72.2% | 102,142 | +77.1% | 0.00% | +100.0% |
Q1 2018 | $712,000 | +256.0% | 57,670 | +280.7% | 0.00% | 0.0% |
Q3 2016 | $200,000 | +27.4% | 15,149 | +22.2% | 0.00% | – |
Q2 2016 | $157,000 | -4.3% | 12,399 | 0.0% | 0.00% | -100.0% |
Q1 2016 | $164,000 | -52.7% | 12,399 | -45.1% | 0.00% | 0.0% |
Q4 2015 | $347,000 | +53.5% | 22,581 | +24.2% | 0.00% | 0.0% |
Q3 2015 | $226,000 | -71.1% | 18,187 | -68.8% | 0.00% | -75.0% |
Q3 2014 | $783,000 | -1.0% | 58,344 | +18.4% | 0.00% | -20.0% |
Q2 2014 | $791,000 | -0.1% | 49,295 | +12.2% | 0.01% | 0.0% |
Q1 2014 | $792,000 | +34.2% | 43,921 | +15.2% | 0.01% | +25.0% |
Q4 2013 | $590,000 | -35.4% | 38,139 | -37.9% | 0.00% | -50.0% |
Q3 2013 | $914,000 | +73.4% | 61,456 | +50.9% | 0.01% | +60.0% |
Q2 2013 | $527,000 | – | 40,719 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kent Lake Capital LLC | 925,000 | $12,154,500 | 4.67% |
EVR Research LP | 1,289,037 | $16,937,946 | 4.48% |
Tamarack Advisers, LP | 435,000 | $5,715,900 | 3.70% |
KESTREL INVESTMENT MANAGEMENT CORP | 263,900 | $3,468 | 2.19% |
Tamarack Advisers, LP | 200,000 | $2,628,000 | 1.70% |
Numerai GP LLC | 274,319 | $3,604,552 | 1.20% |
Smith, Graham & Co., Investment Advisors, LP | 525,915 | $6,910,523 | 0.86% |
PEREGRINE CAPITAL MANAGEMENT LLC | 585,254 | $7,690,238 | 0.23% |
WESTFIELD CAPITAL MANAGEMENT CO LP | 2,401,754 | $31,559,048 | 0.22% |
FULLER & THALER ASSET MANAGEMENT, INC. | 2,543,242 | $33,418,194 | 0.19% |